Literature DB >> 9067750

Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene.

J A van den Hurk1, M Schwartz, H van Bokhoven, T J van de Pol, L Bogerd, A J Pinckers, E M Bleeker-Wagemakers, I H Pawlowitzki, K Rüther, H H Ropers, F P Cremers.   

Abstract

Choroideremia (CHM) is an X-linked recessive eye disease that results from mutations involving the Rab escort protein-1 (REP-1) gene. In 18 patients deletions of different sizes have been found. Two females suffering from CHM were reported to have translocations that disrupt the REP-1 gene. In 22 patients, small mutations have been identified. Interestingly, these are all nonsense, frameshift or splice-site mutations; with one possible exception, missense mutations have not been found. This comprises all the known mutations in the disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9067750     DOI: 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.0.CO;2-D

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  48 in total

1.  Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia.

Authors:  M Flynn Roberts; G A Fishman; D K Roberts; J R Heckenlively; R G Weleber; R J Anderson; S Grover
Journal:  Br J Ophthalmol       Date:  2002-06       Impact factor: 4.638

2.  Choroideremia Is a Systemic Disease With Lymphocyte Crystals and Plasma Lipid and RBC Membrane Abnormalities.

Authors:  Alice Yang Zhang; Naveen Mysore; Hojatollah Vali; Jamie Koenekoop; Sang Ni Cao; Shen Li; Huanan Ren; Vafa Keser; Irma Lopez-Solache; Sorath Noorani Siddiqui; Ayesha Khan; Jeannie Mui; Kelly Sears; Jim Dixon; Jeremy Schwartzentruber; Jacek Majewski; Nancy Braverman; Robert K Koenekoop
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

3.  Clinical utility gene card for: choroideremia.

Authors:  Mariya Moosajee; Simon C Ramsden; Graeme C M Black; Miguel C Seabra; Andrew R Webster
Journal:  Eur J Hum Genet       Date:  2013-08-21       Impact factor: 4.246

4.  Microsatellite markers for the cone-rod retinal dystrophy gene, CRX, on 19q13.3.

Authors:  J Bellingham; C Y Gregory-Evans; K Gregory-Evans
Journal:  J Med Genet       Date:  1998-06       Impact factor: 6.318

5.  Identifying characteristic features of the retinal and choroidal vasculature in choroideremia using optical coherence tomography angiography.

Authors:  A Abbouda; A M Dubis; A R Webster; M Moosajee
Journal:  Eye (Lond)       Date:  2017-11-17       Impact factor: 3.775

6.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

7.  The role of Rab27a in the regulation of melanosome distribution within retinal pigment epithelial cells.

Authors:  Clare E Futter; José S Ramalho; Gesine B Jaissle; Mathias W Seeliger; Miguel C Seabra
Journal:  Mol Biol Cell       Date:  2004-02-20       Impact factor: 4.138

8.  Loss-of-function mutations in Rab escort protein 1 (REP-1) affect intracellular transport in fibroblasts and monocytes of choroideremia patients.

Authors:  Natalia V Strunnikova; Jennifer Barb; Yuri V Sergeev; Ashwin Thiagarajasubramanian; Christopher Silvin; Peter J Munson; Ian M Macdonald
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

9.  Choroideremia: analysis of the retina from a female symptomatic carrier.

Authors:  Vera L Bonilha; Karmen M Trzupek; Yong Li; Peter J Francis; Joe G Hollyfield; Mary E Rayborn; Nizar Smaoui; Richard G Weleber
Journal:  Ophthalmic Genet       Date:  2008-09       Impact factor: 1.803

10.  Clinical characteristics of a large choroideremia pedigree carrying a novel CHM mutation.

Authors:  Alex S Huang; Leo A Kim; Amani A Fawzi
Journal:  Arch Ophthalmol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.